ozempic vs glp-1 Agonists for Weight Loss: A Side-by-Side Comparison GLP‑1 drugs like Ozempic show

Thirdly, the COVID-19 pandemic significantly impacted the study, with the majority of participants either randomised just before the pandemic or reaching the critical 6 month and 12-month trial milestones during the pandemic

This is referred to as metabolic adaptation, which reduces GLP-1 and GIP levels and increases the orexigenic hormone ghrelin

Jain, M

Accordingly, the focus here is on general patterns rather than subgroup-specific mechanisms

Safety Monitoring: Who Needs Enhanced Lab Surveillance Patients with pre-existing kidney disease, liver cirrhosis, thyroid nodules, or personal/family history of medullary thyroid cancer require more frequent biomarker checks and may not be candidates for GLP-1 therapy

Lancet 385, 20572066